PARTILLION BIOSCIENCE CORPORATION
Biotech · Private
Hydrogel microparticles (Nanovials) for ultra-high-throughput single-cell antibody screening and functional assessment
- Grants
- $6.8M
- 13 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Nanovials for high-throughput analysis and selection of single cells based on secreted bio-products | $219,679 | |
| Federal grant | Department of Health and Human Services · Phase I · Nanovials for high-throughput analysis and selection of single cells based on secreted bio-products | $219,679 | |
| Federal grant | Department of Health and Human Services · Phase I · Magnetic sorting and selection of producer cells based on secretion and growth using nanovial technology | $236,407 | |
| Federal grant | Department of Health and Human Services · Phase I · Magnetic sorting and selection of producer cells based on secretion and growth using nanovial technology | $236,407 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Microparticle reagents for clonal selection of producer cell lines | $255,916 | |
| Federal grant | Department of Health and Human Services · Phase I · High-throughput antibody discovery directly from B cells using nanovial technology | $355,051 | |
| Federal grant | Department of Health and Human Services · Phase I · Multiplexed analysis of secreted proteins from single-cells using high dynamic range nanovials | $275,489 | |
| Federal grant | Department of Health and Human Services · Phase II · Hydrogel microparticle technology for high-throughout screening of chimeric antigen receptor-T cells based on single cell effector function | $754,792 | |
| Federal grant | Department of Health and Human Services · Phase II · Linking antibody sequences to function at the single-cell level using nanovial technology | $767,559 | |
| Federal grant | Department of Health and Human Services · Phase II · Hydrogel microparticle technology for high-throughout screening of chimeric antigen receptor-T cells based on single cell effector function | $741,926 | |
| Federal grant | Department of Health and Human Services · Phase II · Linking antibody sequences to function at the single-cell level using nanovial technology | $731,568 | |
| Federal grant | Department of Health and Human Services · Phase II · Scaling function-first antibody discovery leveraging memory B cells | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Scaling function-first antibody discovery leveraging memory B cells | $1,000,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2174 | Aruvant Sciences | — | — |
| 2175 | Arena Therapeutics OpCo, Inc. | — | $600K |
| 2176 | AFFIRMED PHARMA, LLC | — | — |
| 2177 | PARTILLION BIOSCIENCE CORPORATION | — | — |
| 2178 | AVADIM HEALTH, INC. | — | $81M |
| 2179 | ID4PHARMA, LLC | — | — |
| 2180 | ENABLE LIFE SCIENCES LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.